ESC 2020

2020-08-29 - 2020-09-01
Online, Virtual

ESH 2020

2020-05-29 - 2020-06-01
Online, Virtual

ESC 2019

2019-08-31 - 2019-09-04
Paris, France

ACC 2019

2019-03-17 - 2019-03-19
New Orleans, LA, United States

AHA 2018

2018-11-10 - 2018-11-12
Chicago, United States

ESC 2018

2018-08-25 - 2018-07-29
Munich, Germany

ESC Heart Failure 2018

2018-05-26 - 2018-05-29
Vienna, Austria

ACC 2018

2018-03-10 - 2018-03-12
Orlando, United States

ESC 2017

2017-08-26 - 2017-08-30
Barcelona, Spain
Search in Scientific Content:
Date
Filters:
2020 ESC G
7:33

2020 ESC Guidelines on Adult Congenital Heart Disease

Presenter: Julie De Backer
ESC 2020
EXPLORER-H
11:15

EXPLORER-HCM: Efficacy and Safety of Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Presenter: Iacopo Olivotto
ESC 2020
IMPACT-Afi
11:26

IMPACT-Afib Implementation of Stroke Prevention in Atrial Fibrillation

Presenter: Sean Pokorney
ESC 2020
Tackling c
10:29

Tackling cardiovascular diseases with a new generation of polypills

Presenter: Bryan Williams
ESC 2020
ESC Gold M
14:31

ESC Gold Medal 2020 Winner: Kari Stefansson

Presenter: Kari Stefansson
ESC 2020
ESC Gold M
5:40

ESC Gold Medal 2020 Winner: Stefanie Dimmeler

Presenter: Stefanie Dimmeler
ESC 2020
PCSK9 inhi
9:07

PCSK9 inhibitors from bench to real world: a journey to improve CV outcomes in very high-risk patients

Presenter: Christie M. Ballantyne
ESC 2020
BRACE CORO
12:48

BRACE CORONA: Continuing vs. Suspending ACE Inhibitors and ARBs in COVID-19

Presenter: Gianfranco Parati
ESC 2020
2021 ESC G
15:58

2021 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease

Presenter: Sanjay Sharma
ESC 2020
LoDoCo2 Lo
6:50

LoDoCo2 Low-Dose Colchicine in Coronary Disease

Presenter: Thomas Felix Luscher
ESC 2020
HOME-PE -
5:32

HOME-PE - Hospitalisation or Outpatient Management of PE Patients - HESTIA vs. Simplified PESI

Presenter: Thomas Felix Luscher
ESC 2020
ESC 2020:
5:48

ESC 2020: Best clinical cases - Awards session

Presenter: Allan Bohm
ESC 2020
Persistenc
6:12

Persistence and cardiovascular outcomes with ramipril, atorvastatin, ASA as a single pill compared to the multi pill combination. A subanalysis of the START study, a claims data analysis

Presenter: Burkhard Weisser
ESC 2020
PARALLAX:
10:36

PARALLAX: Sacubitril/Valsartan versus Individualized RAAS Blockade in Patients with HFpEF

Presenter: Burkert Pieske
ESC 2020
Time to re
11:15

Time to reduce the implementation gaps-the role of PCSK9i in routine practice

Presenter: Kausik K Ray
ESC 2020
BPLTTC - B
4:18

BPLTTC - Blood Pressure Lowering for Prevention of Cardiovascular Events across Different Levels of Blood Pressure

Presenter: Kazem Rahimi
ESC 2020
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients.

Presenter: Andreas Goette
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
HOPE 4 - I
5:19

HOPE 4 - Impact on cardiovascular risk of a community based multifaceted intervention in individuals with hypertension in 2 middle income countries: The Heart Outcomes Prevention and Evaluation 4 study

Presenter: J.D. Schwalm
SYNTAXES:
7:28

SYNTAXES: Ten-Year Survival after Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention: The SYNTAX Extended Survival study

Presenter: Daniel Johannes Franciscus Maria Thuijs
MITRA-FR -
8:46

MITRA-FR - 2 years follow-Up of the MITRA-FR study a randomized controlled trial evaluating the effectiveness of percutaneous mitral valve repair in secondary mitral regurgitation

Presenter: Jean-Francois Obadia
DAPA HF Th
6:20

DAPA HF The Dapagliflozin And Prevention Of Adverse-outcomes In Heart Failure Trial

Presenter: John McMurray
CONDI-2/ER
4:010

CONDI-2/ERIC-PPCI Effect of remote ischemic conditioning on clinical outcomes in patients with Stsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Presenter: Hans Erik Botker